Back
Cidara Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
80
CDTX
Cidara Therapeutics, Inc.
Last Price:
$220.85
Seasonality Move:
11.35%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight selling pressure.
Cidara Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 220.41 | Buy |
| 20-day SMA: | 220.21 | Buy |
| 50-day SMA: | 164.03 | Buy |
| 200-day SMA: | 74.75 | Buy |
| 8-day EMA: | 220.29 | Buy |
| 20-day EMA: | 211.51 | Buy |
| 50-day EMA: | 175.19 | Buy |
| 200-day EMA: | 95.79 | Buy |
Cidara Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 14.79 | Buy |
| Relative Strength Index (14 RSI): | 85.13 | Buy |
| Chaikin Money Flow: | -64999 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (219.24 - 220.64) | Buy |
| Bollinger Bands (100): | (56.58 - 180.88) | Buy |
Cidara Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cidara Therapeutics, Inc. Stock
Is Cidara Therapeutics, Inc. Stock a Buy?
-
Cidara Therapeutics, Inc. share price is 220.85 while CDTX 8-day simple moving average is 220.41, which is a Buy signal.
-
The stock price of CDTX is 220.85 while Cidara Therapeutics, Inc. 20-day SMA is 220.21, which makes it a Buy.
-
Cidara Therapeutics, Inc. 50-day simple moving average is 164.03 while CDTX share price is 220.85, making it a Buy technically.
-
CDTX stock price is 220.85 and Cidara Therapeutics, Inc. 200-day simple moving average is 74.75, creating a Buy signal.
CDTX Technical Analysis vs Fundamental Analysis
Buy
80
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Is Cidara Therapeutics, Inc. a Buy or a Sell?
-
Cidara Therapeutics, Inc. stock is rated a BuyThe current Cidara Therapeutics, Inc. [CDTX] share price is $220.85. The Score for CDTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
Cidara Therapeutics, Inc. Stock Info
Market Cap:
6.9B
Price in USD:
220.85
Share Volume:
585K
Cidara Therapeutics, Inc. 52-Week Range
52-Week High:
221.20
52-Week Low:
15.22
Buy
80
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Cidara Therapeutics, Inc. Share Price Forecast
-
What is the Cidara Therapeutics, Inc. stock price today?The Cidara Therapeutics, Inc. stock price is 220.85 USD today.
-
Will CDTX stock go up or go down?Cidara Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Cidara Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cidara Therapeutics, Inc. is not overvalued.
Is Cidara Therapeutics, Inc. Stock a Buy?
-
Cidara Therapeutics, Inc. share price is 220.85 while CDTX 8-day exponential moving average is 220.29, which is a Buy signal.
-
The stock price of CDTX is 220.85 while Cidara Therapeutics, Inc. 20-day EMA is 211.51, which makes it a Buy.
-
Cidara Therapeutics, Inc. 50-day exponential moving average is 175.19 while CDTX share price is 220.85, making it a Buy technically.
-
CDTX stock price is 220.85 and Cidara Therapeutics, Inc. 200-day simple moving average is 95.79, creating a Buy signal.
Fundamental Analysis of Cidara Therapeutics, Inc.
Is Cidara Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.
Technical Analysis of Cidara Therapeutics, Inc.
Should I short Cidara Therapeutics, Inc. stock?
-
CDTX Moving Average Covergence Divergence (MACD) indicator is 14.79, suggesting Cidara Therapeutics, Inc. is a Buy
-
Cidara Therapeutics, Inc. Relative Strength Index (RSI) is 85.13, which suggest Cidara Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Cidara Therapeutics, Inc. is (219.24 - 220.64), which suggest Cidara Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Cidara Therapeutics, Inc. is (56.58 - 180.88), which suggest Cidara Therapeutics, Inc. is a Buy
* Cidara Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.